SCHEMBL29914352

SCHEMBL29914352

COc1ccc(-c2cc(NC3=NC(N)(C4CC4)NC=C3)on2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
SMN1; SMN2 Q16637 4/20 0.35
CYP1A2 P05177 1/20 0.35
FPR1 P21462 1/20 0.34
FPR2 P25090 1/20 0.34
IGF1R P08069 2/20 0.34
MAPT P10636 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.34
SLC6A4 P31645 4/20 0.33
SLC6A3 Q01959 4/20 0.33
SLC6A2 P23975 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29914348 0.80 KMT2A (0.39) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL29914341 0.80 KMT2A (0.41) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL29914351 0.80 KMT2A (0.39) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL22504981 0.68 KMT2A (0.59) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL4464611 0.65 SMN1; SMN2 (0.47) CYP3A4CYP2C9KMT2ANPC1RAB9A
SCHEMBL24590357 0.64 MEN1 (0.55) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL23365218 0.64 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL24590147 0.63 KMT2A (0.54) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL23378499 0.63 CYP3A4 (0.61) CYP3A4CYP2D6CYP2C9MEN1KMT2A
SCHEMBL24590317 0.62 MEN1 (0.53) CYP3A4CYP2D6CYP2C9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115279754-A Isoxazole derivatives targeting TACC3 as anticancer agents A2A制药有限公司 2022-11-01 CN claimed
CN-115279754-A Isoxazole derivatives targeting TACC3 as anticancer agents A2A制药有限公司 2022-11-01 CN disclosed